Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-06-04

Clinical Trial Update: Effects of Benfotiamine on Intraepidermal Nerve Fiber Density (IENFD) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating the effect of benfotiamine on intraepidermal nerve fiber density in diabetic neuropathy. Sponsor: Diabetes Schwerpunktp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Benfotiamine (benfotiamine)

Snippet

Sponsor: Diabetes Schwerpunktpraxis | Conditions: Diabetic Neuropathies | Phase 3 | Status: UNKNOWN